Live feed
Filing
SC 13G
SC 13G0001787092-20-000006·Aligos Therapeutics, Inc.
Schedule 13G ownership disclosure
Aligos Therapeutics, Inc.
Security class unavailable
Event date: 2020-10-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,906,191
- Percent of class
- 5.3400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001787092-20-000006
- Form type
- SC 13G
- Filer
- Aligos Therapeutics, Inc.
- CIK
- CIK 1799448
- Filed
- Oct 22, 2020
- Reporting period
- Oct 12, 2020
- Description
- Schedule 13G beneficial ownership